Repaglinide and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Repaglinide (repaglinide), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Ramipril, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Repaglinide. It is created by eHealthMe based on reports of 8,187 people who have side effects when taking Repaglinide from the FDA, and is updated regularly.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 2,001 drugs and 1,973 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

On Jul, 20, 2026

8,187 people reported to have side effects when taking Repaglinide.
Among them, 13 people (0.16%) have Dermatitis - atopic.

Could Repaglinide cause Dermatitis - atopic?

Among these 13 people:

How long have people been on Repaglinide when they have Dermatitis - atopic? *

What is the gender of people who have Dermatitis - atopic when taking Repaglinide? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Dermatitis - atopic when taking Repaglinide? *

What are other drugs people take besides Repaglinide? *

Ramipril: 4 people, 30.77%
Januvia: 3 people, 23.08%
Diltiazem Hydrochloride: 3 people, 23.08%
Cordarone: 2 people, 15.38%
Plavix: 2 people, 15.38%
Indapamide: 2 people, 15.38%
Lasix: 2 people, 15.38%
Foradil: 2 people, 15.38%
Nexium: 2 people, 15.38%
Glucophage: 2 people, 15.38%

What are other side effects people have besides Dermatitis - atopic? *

Oedema Peripheral (superficial swelling): 3 people, 23.08%
Drug Eruption (adverse drug reaction of the skin): 2 people, 15.38%
Insomnia (sleeplessness): 2 people, 15.38%
Blood Creatinine Increased: 2 people, 15.38%
Itching: 2 people, 15.38%
Haemoglobin Decreased: 2 people, 15.38%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Drug Resistance (reduction in effectiveness of a drug): 1 person, 7.69%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 7.69%
Glycosylated Haemoglobin Increased: 1 person, 7.69%

What are the existing conditions these people have? *

Type 2 Diabetes: 5 people, 38.46%
High Blood Pressure: 4 people, 30.77%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 15.38%
Enlarged Prostate: 2 people, 15.38%
Bone Loss: 1 person, 7.69%
Cardiac Failure: 1 person, 7.69%
Cardiac Failure Chronic: 1 person, 7.69%
Hepatitis C: 1 person, 7.69%
Hiv Infection: 1 person, 7.69%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Repaglinide and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Repaglinide:

Repaglinide (8,226 reports)

Browse all side effects of Repaglinide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (2,001 drugs)

Browse all the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,973 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on repaglinide (the active ingredients of Repaglinide) and Repaglinide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.